Carrus Capital Corp  

(Public, CVE:CHQ)   Watch this stock  
Find more results for CHQ
0.0000 (0.00%)
Jan 13 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.03 - 0.10
Open     -
Vol / Avg. 0.00/332.00
Mkt cap 57,310.00
P/E 59.52
Div/yield     -
EPS 0.00
Shares 2.29M
Beta 0.36
Inst. own     -

Key stats and ratios

Q4 (Oct '15) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets 35.27% -33.51%
Return on average equity 685.84% -57.31%
Employees 6 -
CDP Score - -


885 West Georgia Street, Unit 1320
+1-604-3755578 (Phone)
+1-604-2219688 (Fax)

Website links


Carrus Capital Corporation is a Canada-based investment issuer. The Company is engaged in the identification and strategic investment in a diversified portfolio of public and private companies for capital growth. The Company also invests in the securities of companies, assets and businesses. The Company's investment objective is to increase shareholder value through the identification of and investment in securities of publicly listed corporations offering capital appreciation potential. The Company's subsidiaries include BioAB Strategies Ltd. (BioAB), BioDE Ventures Ltd. (BioDE) and BioHEP Technologies Ltd. (BioHEP). The biotechnology assets of its subsidiaries include Omigard and MX-226, CLS001, MX-2401 and MX-1313.

Officers and directors

Douglas B. Johnson Independent Chairman of the Board
Age: 1
Ann Fehr Chief Financial Officer
Chester Shynkaryk Chief Executive Officer, Director
Bruce A. Schmidt Secretary, Director
Age: 58
Gordon Medland Director